{"id":"W2114612266","doi":"10.1200/jco.2006.07.6547","title":"Phase I/II Trial of Erlotinib and Cisplatin in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Princess Margaret Hospital Phase II Consortium and National Cancer Institute of Canada Clinical Trials Group Study","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Erlotinib; Internal medicine; Head and neck squamous-cell carcinoma; Phases of clinical research; Toxicity; Erlotinib Hydrochloride; Oncology; Cisplatin; Head and neck cancer; Gastroenterology; Progressive disease; Chemotherapy; Clinical endpoint; Cancer; Epidermal growth factor receptor; Surgery; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009825644,0.0001687833,0.002863952,0.0001075605,0.00007262538,0.000002552026,0.0001003262,0.0001223073,0.00001500486],"category_scores_gemma":[0.009364425,0.00009005749,0.0001432273,0.0001814325,0.0006443024,0.00008004443,0.0001169452,0.0005780809,7.619774e-9],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001045564,"about_ca_system_score_gemma":0.004809974,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003690191,"about_ca_topic_score_gemma":0.1022722,"domain_scores_codex":[0.9932039,0.0008353071,0.004841328,0.0002364094,0.0006809264,0.000202157],"domain_scores_gemma":[0.9906122,0.004595845,0.003773053,0.0001155675,0.0006389352,0.0002643967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2741256,0.03626877,0.6335415,0.000140014,0.0003490009,0.00009192909,0.0007339202,0.000001462634,0.000009346239,0.00001267221,0.0003689898,0.05435681],"study_design_scores_gemma":[0.2967578,0.1975067,0.5040784,0.000150943,0.0004645383,0.000007367382,0.0002879992,0.00001487785,0.00001995242,0.000008116203,0.0006414121,0.00006185339],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955426,0.0005304395,0.000005314938,0.0008055173,0.001441681,0.001520179,0.00008570365,9.596898e-7,0.00006758534],"genre_scores_gemma":[0.9990457,0.0001699603,0.0003318722,0.0001694867,0.000246737,0.00001008576,0.000001990165,0.000008441891,0.00001577325],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.161238,"threshold_uncertainty_score":0.9989801,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1661829989492623,"score_gpt":0.5044481561739024,"score_spread":0.3382651572246401,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}